Updated: March 19, 2021 BPOM encourages self-reliance in human cell-based drug production Must Read Nationalindonesianupdates.com_admin - November 27, 2025Indonesia monitors citizens after deadly Hong Kong apartment fire Nationalindonesianupdates.com_admin - November 27, 2025Gibran orders upgrade of ‘Lapor Mas Wapres’ complaint channel Nationalindonesianupdates.com_admin - November 27, 2025Energy Minister backs TNI role in securing strategic assets The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production. “This guide also … Previous articleKadin confirms 3.5 million registered for self-funded vaccinationNext articleGovernment should not delay and pay holiday allowance for 2021: KSPI Latest News National - November 27, 2025Indonesia monitors citizens after deadly Hong Kong apartment fireThe Indonesian Consulate General (KJRI) in Hong Kong is closely monitoring the condition of Indonesian citizens ... National Gibran orders upgrade of ‘Lapor Mas Wapres’ complaint channel - November 27, 2025 National Energy Minister backs TNI role in securing strategic assets - November 27, 2025 National RI Govt vows to enforce law over operations at IMIP airport - November 27, 2025 National Indonesia launches US$150M program to modernize C-130 Hercules fleet - November 27, 2025 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production.